Home > Boards > Canadian > Cannabis > AREV NanoTec Brands Inc. (AREVF)


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
maddog gene Member Profile
Followed By 20
Posts 1,781
Boards Moderated 0
Alias Born 01/19/11
160x600 placeholder
maddog gene   Friday, 04/17/20 11:33:08 AM
Re: None
Post # of 9 
Press Release | 04/13/2020
VANCOUVER, BC / April 9, 2020 / AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVD) ("AREV Brands") is pleased to announce that it has completed an asset purchase and sale agreement (the "Acquisition Agreement") dated April 4, 2020 with Chiron Capital Inc, a wholly owned BC Corporation of Mike Withrow. The Company has acquired certain intellectual property, engineering know-how, business models and trade secrets related to extraction technology of the equipment AREV had previously purchased from Alternative Extracts Inc.

The rights title and interest to the Intellectual property were purchased for CAD $200,000 free and clear of any encumbrances. The Company believes owning this key technology and methods to the equipment it already owns advance the Company forward in the current market. Now AREV has ownership of advanced IP and technology and does not have to rely on a vendor to make custom changes to the equipment when innovating and developing its new nano particulate extraction products. Having this IP enables the company to develop proprietary process high value pharmaceutical grade compounds such as Fondoside -A, piperine, and curcumin.

AREV has developed proprietary methods to extract and produce nano particulates from raw materials like astaxanthin, sea cucumber, hops, Frankinsence, myrrh, ginseng, kampot pepper, turmeric and functional mushrooms. On a recent trip to Vietnam Mr. Withrow sourced a fabrication company who is manufacturing custom centrifuges, screw presses and grinders for AREV. These pieces are all part of the methodology and systems AREV can now produce from the IP. For example Frankinsence contains a little know compound called viridiflorol, which has shown moderate antibacterial activity against Mycobacterium tuberculosis, the causative agent of tuberculosis, in an in vitro assay. It is also an effective anti-inflammatory. This is just one example of the many high value compounds the company can now produce.

The company recently changed its name to better reflect the innovation with nanotechnology it is working on with a focus on extracting and fractioning compounds used in the fight against inflammation and viral infections.

Mr. Withrow stated This acquisition gives AREV the ability to keep trade secrets proprietary and file patents on our technology and methods in our own name. He went on to say, We now have a solid competitive advantage and we are diversified in the biomass we can process on any scale.

For further information, contact Mike Withrow, mike@AREVBrands.com 778-929-6536.

On behalf of the Board,

Mike Withrow
CEO & Director

About AREV NanoTec Inc.
AREV NanoTec Brands Inc. (AREV) produces and sells functional ingredients produced via its proprietary extraction systems. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition markets. AREVs model is to toll process extraction of targeted essential and functional oils and license its formulations to Licensed Producers in Canada.The company utilizes toll processors in foreign countries to encapsulate and package its formulations that can be sold in traditional distribution channels and online.



Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, and continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Companys Managements Discussion and Analysis under the Companys profile on www.sedar.com.

Back to News Headlines
Other Financial Information
Recent News & Disclosure Filings
Recent SEC Filings

OTCQB Member Since 10/2019
OTCQB Venture
Verified Profile 04/2020

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences